Liofilchem ESBL+AMPC screening disc kit 50 tests

Catalog No :

CAS Number :

Brand :

Availability :

In Stock

Conditions générales
Garantie satisfait ou remboursé de 30 jours
Expédition : 2-3 jours ouvrables

    This combination does not exist.

    Place Inquiry

    This combination does not exist.

    Specifications:
    Application Clinical microbiology
    Storage Temperature 2-8°C
    Product Type Antibiotic Disc
    Product Brand Liofilchem
    Product Grade Microbiology grade

    The Liofilchem™ ESBL+AmpC Screen Disc Kit is a diagnostic tool designed for the screening of ESBL (Extended-Spectrum Beta-Lactamase) and AmpC beta-lactamase-producing organisms. These resistance mechanisms are commonly found in Enterobacteriaceae, particularly Escherichia coli and Klebsiella pneumoniae. This kit utilizes Combination Disc Tests (CDT) to differentiate between ESBL, AmpC, and non-beta-lactamase-producing organisms.

    Key Features

    1. Dual Detection:
      • Differentiates ESBL and AmpC beta-lactamase production in a single assay.
    2. Validated for Clinically Relevant Strains:
      • Includes Klebsiella pneumoniae, Escherichia coli, and Enterobacter cloacae.
    3. CLSI and EUCAST Compliant:
      • Follows international guidelines for resistance mechanism detection.
    4. Convenient Packaging:
      • Contains 4 x 50 discs, each packed in blisters with desiccants for optimal storage.

    Kit Contents

    • 4 x 50 disc cartridges:
      • CTX 30 μg: Cefotaxime.
      • CTL 30+10 μg: Cefotaxime + Clavulanic Acid.
      • CTC 30 μg: Cefotaxime + Cloxacillin.
      • CTLC 30+10 μg: Cefotaxime + Clavulanic Acid + Cloxacillin.

    Method Principle

    • Combination Disc Tests (CDT):
      • The test evaluates the inhibition zone sizes around Cefotaxime discs alone and in combination with inhibitors:
        • Clavulanic Acid: Inhibits ESBL beta-lactamases.
        • Cloxacillin: Inhibits AmpC beta-lactamases.
      • Inhibition zones are compared to detect and differentiate ESBL and AmpC production.

    Test Procedure

    1. Prepare Test Organism:
      • Use a pure, fresh culture to prepare a suspension equivalent to 0.5 McFarland Standard.
    2. Plate Preparation:
      • Spread the bacterial suspension evenly over a Mueller Hinton II Agar plate using a sterile swab.
    3. Disc Application:
      • Apply the discs (CTX, CTL, CTC, and CTLC) onto the plate, ensuring sufficient spacing for measurement.
    4. Incubation:
      • Incubate the plate at 36 ± 1°C for 18–24 hours.
    5. Measure and Interpret Results:
      • Measure inhibition zones and interpret based on the provided table.

    Interpretation of Results

    Antibiotic DiscDifference in Zone DiametersInterpretation
    Cefotaxime + Clavulanic Acid (CTL)≥ 5 mm larger than Cefotaxime (CTX)ESBL
    Cefotaxime + Cloxacillin (CTC)≥ 5 mm larger than Cefotaxime (CTX)AmpC
    Cefotaxime + Clavulanic Acid + Cloxacillin (CTLC)≥ 5 mm larger than Cloxacillin (CTC)ESBL+AmpC
    All Zones Within 2 mmNo differenceNegative for ESBL/AmpC

    Quality Control

    Control StrainESBL PhenotypeAmpC Phenotype
    Klebsiella pneumoniae ATCC® 700603PositiveNegative
    Enterobacter cloacae ATCC® BAA-1143NegativePositive
    Escherichia coli ATCC® 25922NegativeNegative

    Storage and Shelf Life

    • Storage:
      • Unopened blisters: -20°C to +8°C.
      • Opened cartridges: 2-8°C, for up to 7 days.
    • Shelf Life: Valid until the expiry date indicated on the label.

    Advantages

    • Dual Screening: Simultaneously detects ESBL and AmpC production.
    • Standardized: Compliant with CLSI and EUCAST guidelines for antimicrobial resistance detection.
    • User-Friendly: Pre-packaged discs simplify laboratory workflows.
    • Accurate Results: Reliable differentiation between resistance mechanisms.

    Warnings and Precautions

    1. For in vitro diagnostic use (IVD) only.
    2. Handle all microbiological materials as potentially infectious.
    3. Follow standard laboratory safety and aseptic techniques.
    4. Dispose of expired discs and contaminated materials properly.

    Packaging

    DescriptionQuantityCatalog Number
    Cefotaxime 30 μg (CTX)50 discs99008
    Cefotaxime + Clavulanic Acid (CTL)50 discs99008
    Cefotaxime + Cloxacillin (CTC)50 discs99008
    Cefotaxime + Clavulanic Acid + Cloxacillin (CTLC)50 discs99008

    References

    1. Jacoby G.A. AmpC β-Lactamases. Clin Microbiol Rev. 2009; 22(1): 161–182.
    2. EUCAST guidelines for resistance mechanism detection. Version 1.0, 2013.

    Why Choose Liofilchem ESBL+AmpC Screen Disc Kit?

    • Reliable Detection: Differentiates between ESBL and AmpC-producing organisms.
    • Standardized Testing: Compliant with international guidelines for microbiological testing.
    • Easy-to-Use Format: Pre-packaged discs simplify testing workflows in clinical laboratories.

    Product Specification not found.

    Accessory Products


    Add a Review

    Rate this Product  
    Name *
    Email *

    Your Review *
    21665





    0

    0  Reviews
    (0) 
    (0) 
    (0) 
    (0) 
    (0) 

    Customer Review




    Showing 0 Of 0